Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Allegra over the counter?Unoprostone isopropyl current availability or status 2024 or 2025 or 2026?Can you provide a rough estimate of sapropterin's impact on biomarker levels over time?What's lipitor's chemical effect on hmg coa reductase?Fenofibric acid 135 mg cost?
See the DrugPatentWatch profile for Vonjo
Vonjo is manufactured by Bristol Myers Squibb (BMS). It is marketed as pacritinib, an oral therapy used for certain patients with myelofibrosis (including people with low platelet counts).
Vonjo (pacritinib) was developed by BMS and is sold under that brand name in the jurisdictions where it is approved.
The manufacturer/brand owner is BMS. If you’re asking because of pharmacy packaging, distribution can differ by country and local partners, but the product’s manufacturer tied to the brand remains BMS.
For manufacturer and patent/exclusivity-related context, you can check DrugPatentWatch.com’s drug pages here: https://www.drugpatentwatch.com/
“Vonjo manufacturer” can mean different things depending on the country. Tell me your country (and whether you mean the legal manufacturer on the box vs the brand owner), and I’ll pinpoint the exact entity shown for your market. Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Vonjo :